These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33754148)

  • 1. Urinary Phthalate Biomarkers and Bone Mineral Density in Postmenopausal Women.
    Reeves KW; Vieyra G; Grimes NP; Meliker J; Jackson RD; Wactawski-Wende J; Wallace R; Zoeller RT; Bigelow C; Hankinson SE; Manson JE; Cauley JA; Calafat AM
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2567-e2579. PubMed ID: 33754148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary concentrations of phthalate biomarkers and weight change among postmenopausal women: a prospective cohort study.
    Díaz Santana MV; Hankinson SE; Bigelow C; Sturgeon SR; Zoeller RT; Tinker L; Manson JAE; Calafat AM; Meliker JR; Reeves KW
    Environ Health; 2019 Mar; 18(1):20. PubMed ID: 30866962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary phthalate metabolites and the risk of low bone mineral density and osteoporosis in older women.
    Min KB; Min JY
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E1997-2003. PubMed ID: 25050905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary patterns and urinary phthalate exposure among postmenopausal women of the Women's Health Initiative.
    Vieyra G; Hankinson SE; Oulhote Y; Vandenberg L; Tinker L; Mason J; Shadyab AH; Wallace R; Arcan C; Chen JC; Reeves KW
    Environ Res; 2023 Jan; 216(Pt 3):114727. PubMed ID: 36356671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
    Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
    BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of urinary phthalate biomarker concentrations in postmenopausal women.
    Reeves KW; Santana MD; Manson JE; Hankinson SE; Zoeller RT; Bigelow C; Hou L; Wactawski-Wende J; Liu S; Tinker L; Calafat AM
    Environ Res; 2019 Feb; 169():122-130. PubMed ID: 30447499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phthalates and bone mineral density: a systematic review.
    Heilmann NZ; Reeves KW; Hankinson SE
    Environ Health; 2022 Nov; 21(1):108. PubMed ID: 36369032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between bone mineral density and urinary phthalate metabolites among post-menopausal women: a cross-sectional study of NHANES data 2005-2010.
    DeFlorio-Barker SA; Turyk ME
    Int J Environ Health Res; 2016; 26(3):326-45. PubMed ID: 26586408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertebral fracture assessment by dual-energy X-ray absorptiometry along with bone mineral density in the evaluation of postmenopausal osteoporosis.
    Shetty S; John B; Mohan S; Paul TV
    Arch Osteoporos; 2020 Feb; 15(1):25. PubMed ID: 32095943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does hip structural analysis confer additional benefit to routine BMD assessment in postmenopausal women with hip fracture? A study from a tertiary center in southern India.
    Johnson JT; Cherian KE; Kapoor N; Jebasingh FK; Asha HS; Mathai T; Nithyananth M; Oommen AT; Daniel AJ; Thomas N; Paul TV
    Arch Osteoporos; 2022 Feb; 17(1):32. PubMed ID: 35122523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study.
    Beasley JM; LaCroix AZ; Larson JC; Huang Y; Neuhouser ML; Tinker LF; Jackson R; Snetselaar L; Johnson KC; Eaton CB; Prentice RL
    Am J Clin Nutr; 2014 Apr; 99(4):934-40. PubMed ID: 24552750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization.
    Karim R; Dell RM; Greene DF; Mack WJ; Gallagher JC; Hodis HN
    Menopause; 2011 Nov; 18(11):1172-7. PubMed ID: 21775911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial stress and bone loss among postmenopausal women: results from the Women's Health Initiative.
    Follis SL; Bea J; Klimentidis Y; Hu C; Crandall CJ; Garcia DO; Shadyab AH; Nassir R; Chen Z
    J Epidemiol Community Health; 2019 Sep; 73(9):888-892. PubMed ID: 31289118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial Bone Density Measurement and Incident Fracture Risk Discrimination in Postmenopausal Women.
    Crandall CJ; Larson J; Wright NC; Laddu D; Stefanick ML; Kaunitz AM; Watts NB; Wactawski-Wende J; Womack CR; Johnson KC; Carbone LD; Jackson RD; Ensrud KE
    JAMA Intern Med; 2020 Sep; 180(9):1232-1240. PubMed ID: 32730575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
    Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
    J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Association of Pelvic Bone Mineral Density and With Proximal Femoral and Spine Bone Mineral Density in Post-menopausal Women.
    Mohseni M; Eisen S; Stum S; Civitelli R
    J Clin Densitom; 2022; 25(3):328-333. PubMed ID: 35177349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI).
    Harvey NC; Kanis JA; Liu E; Cooper C; Lorentzon M; Bea JW; Carbone L; Cespedes Feliciano EM; Laddu DR; Schnatz PF; Shadyab AH; Stefanick ML; Wactawski-Wende J; Crandall CJ; Johansson H; McCloskey E
    J Bone Miner Res; 2021 Apr; 36(4):654-661. PubMed ID: 33450071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
    Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
    Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.